EUVIMEDEUVIMED entdecken
Crossref

Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats

Janiana Raíza Jentsch Matias de Oliveira, Mayara Alves Amorim, Vitor Hélio de Souza Oliveira, Daniela de Almeida Cabrini, Michel Fleith Otuki, Claudia Martins Galindo, Bruna Barbosa da Luz, Maria Fernanda de Paula Werner, João Batista Calixto, Eunice André

Pulmonary Pharmacology & Therapeutics · 2024

DOI: 10.1016/j.pupt.2024.102302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pulmonary Pharmacology & Therapeutics, 2024. Verfasst von Janiana Raíza Jentsch Matias de Oliveira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Federal University of Paraná, Brazil. Hauptthemen laut MEDLINE: Captopril, TRPV Cation Channels, Bradykinin, Capsaicin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: INCT-INOVAMED, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although TRPV1 receptors play an essential role in the adverse effects on the airways following captopril treatment, there is no available evidence of their involvement in treatment regimens involving repeated doses of captopril. Comparing the difference in these two treatment regimens is essential since captopril is a continuous-use medication. Thus, this study explored the role of the transient receptor potential vanilloid 1 (TRPV1) in the effects of captopril on rat airways using two treatment regimens. Airway resistance, bronchoalveolar lavage (BAL), and histological and immunohistochemical analyses were conducted in rats administered with single or repeated doses of captopril. This study showed that the hyperresponsiveness to bradykinin and capsaicin in captopril-treated rats was acute. Treatment with the selective B2 antagonist, HOE140 reduced bradykinin hyperresponsiveness and abolished capsaicin exacerbation in single-dose captopril-treated rats. Likewise, degeneration of TRPV1-positive neurones also reduced hyperresponsiveness to bradykinin. Single-dose captopril treatment increased leukocyte infiltration in the BAL when compared with the vehicle and this increase was reduced by TRPV1-positive neurone degeneration. However, when compared with the vehicle treatment, animals treated with repeated doses of captopril showed an increase in leukocyte influx as early as 1 h after the last captopril treatment, but this effect disappeared after 24 h. Additionally, an increase in TRPV1 expression occurred only in animals who received repeated captopril doses and the degeneration of TRPV1-positive neurones attenuated TRPV1 upregulation. In conclusion, these data strongly indicate that a treatment regimen involving multiple doses of captopril not only enhances sensitisation but also upregulates TRPV1 expression. Consequently, targeting TRPV1 could serve as a promising strategy to reduce the negative impact of captopril on the airways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaptoprilTRPV Cation ChannelsBradykininCapsaicinBronchoalveolar Lavage FluidAnimalsRatsMaleAngiotensin-Converting Enzyme InhibitorsRats, Sprague-DawleyAirway ResistanceBradykinin B2 Receptor AntagonistsDose-Response Relationship, DrugBronchial HyperreactivityNeurons

Stichwörter der Autor:innen

Airway inflammationBradykininCapsaicinLungTRPV1 upregulation

Substanzen

CaptoprilTRPV Cation ChannelsBradykininCapsaicinTrpv1 protein, ratAngiotensin-Converting Enzyme InhibitorsBradykinin B2 Receptor Antagonists

Autor:innen und Institutionen

  • Department of Pharmacology, Federal University of Paraná, Brazil.
  • Centro de Inovação e Ensaios Pré-Clínicos-CIEnP, Florianópolis, SC, Brazil.
  • Department of Pharmacology, Federal University of Paraná, Brazil. Electronic address: eunice.andre@ufpr.br.

Förderung

  • INCT-INOVAMED
  • CNPq

Zitieren

APA

de Oliveira, J. R. J. M., Amorim, M. A., Oliveira, V. H. S., Cabrini, D. A., Otuki, M. F., Galindo, C. M., da Luz, B. B., Werner, M. F. P., Calixto, J. B., & André, E. (2024). Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats. Pulmonary Pharmacology & Therapeutics. https://doi.org/10.1016/j.pupt.2024.102302

Vancouver

de Oliveira JRJM, Amorim MA, Oliveira VHS, Cabrini DA, Otuki MF, Galindo CM, et al. Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats. Pulmonary Pharmacology & Therapeutics. 2024. doi:10.1016/j.pupt.2024.102302

BibTeX
@article{deOliveira2024,
  author = {de Oliveira, Janiana Raíza Jentsch Matias and Amorim, Mayara Alves and Oliveira, Vitor Hélio de Souza and Cabrini, Daniela de Almeida and Otuki, Michel Fleith and Galindo, Claudia Martins and da Luz, Bruna Barbosa and Werner, Maria Fernanda de Paula and Calixto, João Batista and André, Eunice},
  title = {Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats},
  journal = {Pulmonary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1016/j.pupt.2024.102302}
}
Kostenlos starten →